The European Organisation for Research and Treatment of Cancer (EORTC) is a premier body dedicated to advancing cancer research and enhancing treatment options through a collaborative framework of over 3,800 members across more than 50 countries. With more than 100 active studies and a strong focus on patient involvement, EORTC aims to improve patient outcomes through rigorous clinical research. Their portfolio includes extensive clinical studies, quality assurance initiatives, and educational programs for young and early-career investigators.

EORTC’s commitment to cross-disciplinary collaboration fosters innovative research approaches and the development of comprehensive guidelines, tools, and resources that support clinical trials. The organization also actively engages in public policy advocacy and partnerships with government bodies, reinforcing its mission to shape the future of cancer treatment. Key projects like SPECTA and IMMUcan are among their noteworthy initiatives, paving the way for new treatment standards and improved quality of life for patients.

EORTC continues to be a vital force in the global fight against cancer